Factors related to current and subsequent psychotropic drug use in an elderly cohort

Journal of Clinical Epidemiology

Volumn 50, Issue 3, 1997, Pages 357-364

  Dealberto, Marie José ^a,c   Seeman, Teresa ^b   McAvay, Gail J ^c   Berkman, Lisa ^d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Benzodiazepines; Elderly; Epidemiology; Longitudinal; Psychotropic drugs

Indexed keywords

BENZODIAZEPINE DERIVATIVE; PSYCHOTROPIC AGENT;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DRUG USE; ETHNOLOGY; FEMALE; GENDER; HUMAN; INTERVIEW; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; SLEEP DISORDER; UNITED STATES;

AGED; BENZODIAZEPINES; COHORT STUDIES; CONNECTICUT; DEPRESSION; DRUG UTILIZATION; FEMALE; HUMANS; MALE; PSYCHOTROPIC DRUGS; SLEEP DISORDERS; SOCIOECONOMIC FACTORS;

EID: 0030898531     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(96)00339-3     Document Type: Article

References (37)

1. Mellinger GD, Balter MB, Chase C, Manheimer DI. Patterns of psychotherapeutic drug use among adults in San Francisco. Arch Gen Psych 1971; 25: 385-394.
2. Parry HJ, Balter MB, Mellinger GD, Cisin IH, Manheimer DI. National patterns of psychotherapeutic drug use. Arch Gen Psych 1973; 28: 769-783.
3. Balter MB, Levine J, Manheimer DI. Cross-national study of the extent of anti-anxiety/sedative drug use. N Engl J Med 1974; 290: 769-774.
4. Swartz M, Landerman R, George LK, Melville ML, Blazer D, Smith K. Benzodiazepine anti-anxiety agents: Prevalence and correlates of use in a Southern community. Am J Publ Health 1991; 81: 592-596.
5. Olfson M, Pincus HA. Use of benzodiazepines in the community. Arch Intern Med 1994; 154: 1235-1240.
6. Koenig W, Rüther E, Filipiak B. Psychotropic drug utilization patterns in a metropolitan population. Eur J Clin Pharmacol 1987; 32: 43-51.
7. Isacson D, Haglund B. Psychotropic drug use in a Swedish community - The importance of demographic and socioeconomic factors. Soc Sci Med 1988; 26: 477-483.
8. Allgulander C. Psychoactive drug use in a general population sample, Sweden: Correlates with perceived health, psychiatric diagnoses, and mortality in an automated record-linkage study. Am J Public Health 1989; 79: 1006-1010.
9. Dunbar GC, Perera MH, Jenner FA. Patterns of benzodiazepine use in Great Britain as measured by a general population survey. Brit J Psychiatry 1989; 155: 836-841.
10. Fichter MM, Witzke W, Leibl K, Hippius H. Psychotropic drug use in a representative community sample: The Upper Bavarian study. Acta Psych Scand 1989; 80: 68-77.
11. Vásquez-Barquero JL, Diez Manrique JF, Peña C, Arenal Gonzales A, Cuesta MJ, Artal JA. Patterns of psychotropic drug use in a Spanish rural community. Br J Psych 1989; 155: 633-641.
12. Pariente P, Lépine JP, Lellouch J. Self-reported psychotropic drug use and associated factors in a French community sample. Psychol Med 1992; 22: 181-190.
13. Mellinger GD, Balter MB, Uhlenhuth EH. Prevalence and correlates of the long-term regular use of anxiolytics. JAMA 1984; 251: 375-379.
14. Isacson D, Carsjö K, Haglund B, Smedby B. Psychotropic drug use in a Swedish community - Patterns of individual use during 2 years. Soc Sci Med 1988; 27: 263-267.
15. Stewart RB, May FE, Moore MT, Hale WE. Changing patterns of psychotropic drug use in the elderly: A five-year update. DICP 1989; 23: 610-613.
16. Isacson D, Carsjö K, Bergman U, Blackburn JL. Long-term use of benzodiazepines in a Swedish community: an eight-year follow-up. J Clin Epidemiol 1992; 45: 429-436.
17. Van der Waals FW, Mohrs J, Foets M. Sex differences among recipients of benzodiazepines in Dutch general practice. Br Med J 1993; 307: 363-366.
18. Stewart RB, May FE, Hale WE, Marks RG. Psychotropic drug use in an ambulatory elderly population. Gerontology 1982; 28: 328-335.
19. Morgan K, Dallosso H, Ebrahim S, Arie T, Fentem PH. Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home. Br Med J 1988; 296: 601-602.
20. Rozzini R, Carabellese C, Franzoni S, Inzoli M, Trabucchi M. Pattern of use of hypnotic drugs among the elderly living at home. Pharmacol Res Comm 1988; 20S11: 333.
21. Smart RG, Adlaf EM. Alcohol and drug use among the elderly: Trends in use and characteristics of users. Can J Public Health 1988; 79: 236-242.
22. Ried LD, Christensen DB, Stergachis A. Medical and psychosocial factors predictive of psychotropic drug use in elderly patients. Am J Publ Health 1990; 80: 1349-1353.
23. Laukkanen P, Heikkinen E, Kauppinen M, Kallinen M. Use of drugs by non-institutionalized urban Finns born in 1904-1923 and the association of drug use with mood and self-rated health. Age Ageing 1992; 21: 343-352.
24. Mayer-Oakes SA, Kelman G, Beers MH, De Jong F, Matthias R, Atchison KA, Lubben JE, Schweitzer SO. Benzodiazepine use in older, community-dwelling southern Californians: Prevalence and clinical correlates. Ann Pharmacother 1993; 27: 416-421.
25. Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (part I). Clin Pharmacokinet 1991; 21: 165-177.
26. Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (part II). Clin Pharmacokinet 1991; 21: 262-273.
27. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988; 319: 1701-1707.
28. Bedry R, Dartigues JF, Gagnon M, Barberger-Gateau P, Begaud B, Salamon R, the PAQUID Research Group. The role of benzodiazepines consumption on cognitive functioning in elderly French community residents. J Clin Res Pharmacoepidemiol 1990; 4: 135.
29. Dealberto MJ, Poncet M, Alpérovitch A. Is psychotropic drug use associated to low cognitive performance independent of depression? Neuroepidemiology 1993; 12: 8-9.
30. Cornoni-Huntley J, Blazer DG, Service C, Farmer ME. Introduction. In: Cornoni-Huntley J, Blazer DG, Lafferty ME, Everett DF, Brock DB, Farmer ME, Eds. Established Populations for Epidemiologic Studies of the Elderly. Volume II. Resource Data Book. Bethesda, MD: National Institutes of Health Publication No. 90-495; 1990, pp. 1-7.
31. Berkman L, Berkman C, Kasl S, Freeman D, Leo L, Ostfeld A, Cornoni-Huntley J, Brody J. Depressive symptoms in relation to physical health and functioning in the elderly. Am J Epidemiol 1986; 124: 372-388.
32. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
33. Comstock GW, Helsing KJ. Symptoms of depression in two communities. Psychol Med 1976; 6: 551-563.
34. Seeman T, Mendes de Leon C, Berkman L, Ostfeld A. Risk factors for coronary heart disease among older men and women: A prospective study of community-dwelling elderly. Am J Epidemiol 1993; 138: 1037-1049.
35. Freeman D, Bruce ML, Leaf P, Berkman L. Sampling strategies for studying older populations. In: Wallace R, Woolson R, Eds. Methodologic Issues in the Epidemiologic Study of the Elderly. New York: Oxford University Press; 1992, pp. 46-59.
36. Lader M, Petursson H. Long-term effects of benzodiazepines. Neuropharmacology 1983; 22: 527-533.
37. Committee on the review of medicines. Systematic review of the benzodiazepines. Guidelines for datasheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Br Med J 1980; 280: 910-912.